You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,154.8% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.4 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 13.1 | n/a |
| Price / Book value | 1.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | n/a | -3.12 | -2.70p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-03-31 | n/a | -3.17 | -2.07p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-03-31 | 0.19 | -3.21 | -1.82p | -4.1 | 0.0 | n/a | n/a | 0.0% |
| 2022-03-31 | n/a | -3.17 | -0.99p | -3.5 | 0.0 | n/a | n/a | 0.0% |
| 2023-03-31 | 0.44 | -5.01 | -1.47p | -2.5 | 0.0 | n/a | n/a | 0.0% |
| Evgen Pharma doses first volunteers in SFX-01 trial Sharecast News | 16 Nov |
|---|---|
| Evgen starts recruiting volunteers for trial of lead asset Sharecast News | 12 Oct |
| Directorate Changes | 05-Sep-23 14:08 |
|---|---|
| Final Report from Phase 1b PK/PD study | 15-Aug-23 14:15 |
| Rule 17 Disclosure | 03-Aug-23 21:14 |
| Return of rights to Sulforadex from Juvenescence | 02-Aug-23 14:13 |
| Result of AGM | 21-Jul-23 20:02 |